China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.05 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$114B	$23.7 Million 2.26% of portfolio	48,866	Q1 2025 Reduced 6.71%
REGN Regeneron Pharmaceuticals, Inc.	$63.4B	$16.3 Million 1.55% of portfolio	25,629	Q1 2025 Added 3.87%
ALNY Alnylam Pharmaceuticals, Inc.	$35.1B	$8.36 Million 0.8% of portfolio	30,971	Q1 2025 Reduced 20.58%
ARGX Argenx Se	$31.9B	$3.8 Million 0.36% of portfolio	6,421	Q1 2025 Reduced 6.08%
RVMD Revolution Medicines, Inc.	$3.31B	$3.18 Million 0.3% of portfolio	89,962	Q1 2025 Added 45.15%
SMMT Summit Therapeutics Inc.	$5.19B	$2.85 Million 0.27% of portfolio	147,966	Q1 2025 Reduced 5.37%
UTHR United Therapeutics Corp	$14.4B	$2.78 Million 0.27% of portfolio	9,009	Q1 2025 Reduced 4.83%
INSM Insmed Inc	$8.99B	$2.77 Million 0.26% of portfolio	36,305	Q1 2025 Reduced 4.29%
BMRN Biomarin Pharmaceutical Inc	$10.8B	$2.73 Million 0.26% of portfolio	38,640	Q1 2025 Reduced 5.26%
RPRX Royalty Pharma PLC	$14.3B	$2.71 Million 0.26% of portfolio	86,918	Q1 2025 Reduced 7.74%
INCY Incyte Corp	$14.4B	$2.35 Million 0.22% of portfolio	38,818	Q1 2025 Reduced 4.97%
MRNA Moderna, Inc.	$10.2B	$2.22 Million 0.21% of portfolio	78,191	Q1 2025 Reduced 5.11%
EXEL Exelixis, Inc.	$13.6B	$2.07 Million 0.2% of portfolio	56,139	Q1 2025 Reduced 7.29%
BGNE Bei Gene, Ltd.	$23.5B	$1.9 Million 0.18% of portfolio	8,394	Q1 2025 Reduced 10.73%
ASND Ascendis Pharma A/S	$8.89B	$1.89 Million 0.18% of portfolio	12,113	Q1 2025 Reduced 5.29%
BNTX Bio N Tech Se	$23.7B	$1.82 Million 0.17% of portfolio	20,036	Q1 2025 Reduced 4.13%
HALO Halozyme Therapeutics, Inc.	$7.58B	$1.58 Million 0.15% of portfolio	24,702	Q1 2025 Reduced 8.43%
JAZZ Jazz Pharmaceuticals PLC	$6.71B	$1.51 Million 0.14% of portfolio	12,182	Q1 2025 Reduced 4.97%
MDGL Madrigal Pharmaceuticals, Inc.	$4.63B	$1.47 Million 0.14% of portfolio	4,429	Q1 2025 Reduced 4.24%
VRNA Verona Pharma PLC	$4.51B	$1.46 Million 0.14% of portfolio	22,967	Q1 2025 Added 0.52%
ROIV Roivant Sciences Ltd.	$7.48B	$1.44 Million 0.14% of portfolio	143,126	Q1 2025 Reduced 7.27%
NVO Novo Nordisk A S	$155B	$1.39 Million 0.13% of portfolio	20,000	Q4 2024 Reduced 4.76%
BBIO Bridge Bio Pharma, Inc.	$4.78B	$1.32 Million 0.13% of portfolio	38,149	Q1 2025 Reduced 4.8%
SRPT Sarepta Therapeutics, Inc.	$3.26B	$1.24 Million 0.12% of portfolio	19,463	Q1 2025 Reduced 3.91%
AXSM Axsome Therapeutics, Inc.	$4.42B	$1.14 Million 0.11% of portfolio	9,782	Q1 2025 Reduced 4.81%
BPMC Blueprint Medicines Corp	$5.69B	$1.13 Million 0.11% of portfolio	12,818	Q1 2025 Reduced 4.84%
KRYS Krystal Biotech, Inc.	$3.17B	$1.04 Million 0.1% of portfolio	5,778	Q1 2025 Reduced 5.25%
PCVX Vaxcyte, Inc.	$1.86B	$975,000 0.09% of portfolio	25,827	Q1 2025 Reduced 2.27%
IONS Ionis Pharmaceuticals Inc	$4.6B	$962,000 0.09% of portfolio	31,886	Q1 2025 Reduced 4.76%
CYTK Cytokinetics Inc	$2.85B	$954,000 0.09% of portfolio	23,751	Q1 2025 Reduced 5.08%
NUVL Nuvalent, Inc.	$3.07B	$941,000 0.09% of portfolio	13,271	Q1 2025 Reduced 4.61%
ADMA Adma Biologics, Inc.	$3.83B	$940,000 0.09% of portfolio	47,416	Q1 2025 Reduced 5.4%
IMVT Immunovant, Inc.	$3.55B	$937,000 0.09% of portfolio	34,071	Q1 2025 Added 9.47%
PTGX Protagonist Therapeutics, Inc	$2.25B	$907,000 0.09% of portfolio	18,772	Q1 2025 Added 48.55%
GMAB Genmab A/S	$13.9B	$904,000 0.09% of portfolio	46,202	Q1 2025 Added 419.65%
PTCT Ptc Therapeutics, Inc.	$3.38B	$806,000 0.08% of portfolio	15,820	Q1 2025 Reduced 3.26%
ACLX Arcellx, Inc.	$2.71B	$722,000 0.07% of portfolio	11,021	Q1 2025 Reduced 3.88%
AMRN Amarin Corp Plcuk	$4.55B	$719,000 0.07% of portfolio	80,323	Q1 2025 Reduced 5.36%
RNA Avidity Biosciences, Inc.	$1.61B	$711,000 0.07% of portfolio	24,113	Q1 2025 Reduced 4.68%
RYTM Rhythm Pharmaceuticals, Inc.	$3.34B	$671,000 0.06% of portfolio	12,682	Q1 2025 Reduced 2.68%
RARE Ultragenyx Pharmaceutical Inc.	$2.41B	$671,000 0.06% of portfolio	18,554	Q1 2025 Reduced 5.24%
SWTX Spring Works Therapeutics, Inc.	$2.91B	$663,000 0.06% of portfolio	15,031	Q1 2025 Reduced 4.7%
AKRO Akero Therapeutics, Inc.	$2.1B	$646,000 0.06% of portfolio	15,970	Q1 2025 Added 7.91%
CRNX Crinetics Pharmaceuticals, Inc.	$1.61B	$625,000 0.06% of portfolio	18,664	Q1 2025 Reduced 5.09%
SRRK Scholar Rock Holding Corp	$1.59B	$610,000 0.06% of portfolio	18,991	Q1 2025 Reduced 4.33%
CRSP Crispr Therapeutics Ag	$2.9B	$585,000 0.06% of portfolio	17,205	Q1 2025 Reduced 4.93%
MRUS Merus N.V.	$2.29B	$583,000 0.06% of portfolio	13,858	Q1 2025 Reduced 4.54%
ACAD Acadia Pharmaceuticals Inc	$3.56B	$555,000 0.05% of portfolio	33,455	Q1 2025 Reduced 5.18%
LEGN Legend Biotech Corp	$4.74B	$555,000 0.05% of portfolio	16,385	Q1 2025 Reduced 5.4%
APLS Apellis Pharmaceuticals, Inc.	$1.85B	$550,000 0.05% of portfolio	25,176	Q1 2025 Reduced 4.55%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.